The application relates to inhibitors of USP1 useful in the treatment of cancers, and other USP1 associated diseases and disorders, having the Formula: (I), where R 1 , R 2 , R 3 , R 3' , R 4 , R 5 , X 1 , X 2 , X 3 , X 4 , and n are described herein.